LYN-172

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLYN-172
Drug Alias NameHIV Therapy (Lyndra Therapeutics/Lyndra (China) Pharmaceuticals)HIV Therapy (Gilead)HIV therapy (Lyndra/Lyndra (China) Pharmaceuticals)HIV Therapy (Lyndra)LYN-172
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLyndra Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLyndra Therapeutics IncGilead Sciences Inc
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A